Pepgen Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.98

+0.14 (+4.93%)

As of Sep 22, 10:03 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 1 7%

Sell 1 7%

Price Target

Analyst Price Target +1,207.7% upside

Low Target $29.17

Average Target $38.97

High Target $44.78

Current Price $2.98

Current
$2.98

Target
$38.97

$29.17 $38.97 avg $44.78

Scenario Analysis

Bear Case

$29.17

878.9%

Low target

Base Case

$38.97

+1,207.7%

Avg target

Bull Case

$44.78

+1,402.7%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$7.80

-61.8% from high

52-Week Low

$1.31

+127.5% from low

Target vs 52W High

$38.97

+399.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%